Geron-logo-black-xsmall.png
Geron to Present at the Needham Healthcare Conference
April 05, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present...
Geron-logo-black-xsmall.png
Geron Announces Presentations at American Association of Cancer Research Annual Meeting
March 17, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., March 17, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that two abstracts describing non-clinical data on imetelstat have been accepted for...
Geron-logo-black-xsmall.png
Geron Corporation Reports Fourth Quarter and Annual 2015 Financial Results
February 25, 2016 16:05 ET | Geron Corporation
MENLO PARK, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2015 and recent events. ...
Geron-logo-black-xsmall.png
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2015 Financial Results
February 17, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2015, on Thursday,...
Geron-logo-black-xsmall.png
Geron to Present at the RBC Capital Markets Healthcare Conference
February 10, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., Feb. 10, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron-logo-black-xsmall.png
Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes
January 14, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., Jan. 14, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the dosing of the first patient in a Phase 2/3 clinical trial to evaluate imetelstat in...
Geron-logo-black-xsmall.png
Geron Announces December Conference Presentation Webcasts
November 30, 2015 07:30 ET | Geron Corporation
MENLO PARK, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present...
Geron-logo-black-xsmall.png
Geron to Present At the Stifel Healthcare Conference
November 10, 2015 07:30 ET | Geron Corporation
MENLO PARK, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron-logo-black-xsmall.png
Geron Corporation Reports Third Quarter 2015 Financial Results
November 05, 2015 16:05 ET | Geron Corporation
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the third quarter ended September 30, 2015. For the third quarter of...
Geron-logo-black-xsmall.png
Geron Announces Presentations at American Society of Hematology Annual Meeting
November 05, 2015 09:03 ET | Geron Corporation
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that three abstracts describing clinical and non-clinical data on imetelstat have been...